Too few women who pause breast cancer treatment during pregnancy resume therapy after delivery Stanford Medicine-led research found that only one-third of women who pause hormone therapy to become pregnant resumed treatment and that the rates of recurrence in this population were doubled.

Too few women who pause breast cancer treatment during pregnancy resume therapy after delivery! #TCSC #standfordmed #breastcancer #cancertreatment #pregnancy #cancerpatients #oncology #chemolife

med.stanford.edu/news/all-new...